The findings from this study may aid in developing symptomatic treatments for ataxia (imbalance) in disorders presenting with dysfunctional cerebellar BDNF–TrkB signalling, such as SCA6 and SCA1. The gene discussed is NTRK2; the disease is cerebellar ataxia.